Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
S81694
i
Other names:
S81694, NMS-P153, S 81694, NMS P153, NMSP153, S-81694
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Nerviano Medical Sciences, Servier
Drug class:
TTK inhibitor
Related drugs:
‹
VRN08 (1)
CFI-402257 (1)
BAL0891 (0)
NMS-153 (0)
BAY1161909 (0)
VRN08 (1)
CFI-402257 (1)
BAL0891 (0)
NMS-153 (0)
BAY1161909 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
BCR-ABL1 fusion
B Acute Lymphoblastic Leukemia
BCR-ABL1 fusion
B Acute Lymphoblastic Leukemia
dasatinib + nilotinib + YD312 + S81694
Sensitive: D – Preclinical
dasatinib + nilotinib + YD312 + S81694
Sensitive
:
D
dasatinib + nilotinib + YD312 + S81694
Sensitive: D – Preclinical
dasatinib + nilotinib + YD312 + S81694
Sensitive
:
D
BCR-ABL1 E255K
B Acute Lymphoblastic Leukemia
BCR-ABL1 E255K
B Acute Lymphoblastic Leukemia
S81694
Sensitive: D – Preclinical
S81694
Sensitive
:
D
S81694
Sensitive: D – Preclinical
S81694
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login